JP2023513158A5 - - Google Patents
Info
- Publication number
- JP2023513158A5 JP2023513158A5 JP2022547675A JP2022547675A JP2023513158A5 JP 2023513158 A5 JP2023513158 A5 JP 2023513158A5 JP 2022547675 A JP2022547675 A JP 2022547675A JP 2022547675 A JP2022547675 A JP 2022547675A JP 2023513158 A5 JP2023513158 A5 JP 2023513158A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cancer
- antigen
- cell
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970496P | 2020-02-05 | 2020-02-05 | |
| US62/970,496 | 2020-02-05 | ||
| PCT/US2021/015362 WO2021158413A1 (en) | 2020-02-05 | 2021-01-28 | Novel lilrb2 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513158A JP2023513158A (ja) | 2023-03-30 |
| JP2023513158A5 true JP2023513158A5 (https=) | 2024-02-06 |
| JP7767291B2 JP7767291B2 (ja) | 2025-11-11 |
Family
ID=77199417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547675A Active JP7767291B2 (ja) | 2020-02-05 | 2021-01-28 | 新規のｌｉｌｒｂ２抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12596122B2 (https=) |
| EP (1) | EP4100439A4 (https=) |
| JP (1) | JP7767291B2 (https=) |
| KR (1) | KR20220137032A (https=) |
| CN (1) | CN115768793A (https=) |
| AU (1) | AU2021216361A1 (https=) |
| BR (1) | BR112022015450A2 (https=) |
| CA (1) | CA3165532A1 (https=) |
| WO (1) | WO2021158413A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11680101B2 (en) | 2017-01-27 | 2023-06-20 | Kymab Limited | Anti-OPG antibodies |
| FI3661935T3 (fi) | 2017-08-11 | 2023-01-13 | Kinaasin estäjinä käyttökelpoiset pyratsolipyrimidiinit | |
| WO2023039613A2 (en) * | 2021-09-13 | 2023-03-16 | The Board Of Regents Of The University Of Texas System | Lilrb2-specific monoclonal antibodies and methods of their use |
| EP4486383A2 (en) * | 2022-03-04 | 2025-01-08 | D2M Biotherapeutics Limited | Anti-lilrb1/2 antibodies and uses thereof |
| CN116333127B (zh) * | 2022-06-28 | 2026-03-24 | 北京科诺信诚科技有限公司 | 靶向人lilrb2的纳米抗体及其应用 |
| TW202409088A (zh) * | 2022-07-08 | 2024-03-01 | 中國商科望（蘇州）生物醫藥科技有限公司 | 抗lilrb2抗體及其用途 |
| CN119604531A (zh) * | 2022-07-29 | 2025-03-11 | 盛禾(中国)生物制药有限公司 | 一种抗ilt4的单域抗体及其应用 |
| CN115044549B (zh) * | 2022-08-12 | 2023-02-07 | 北京科途医学科技有限公司 | 用于保持免疫细胞多样性的培养基和细胞组合物的培养方法 |
| CN119768432A (zh) * | 2022-08-22 | 2025-04-04 | 德琪(杭州)生物有限公司 | 新颖的抗lilrb2抗体和其用途 |
| EP4491230A1 (en) * | 2023-07-14 | 2025-01-15 | iOmx Therapeutics AG | Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2, combinations and uses thereof |
| AU2023410277A1 (en) * | 2022-12-23 | 2025-06-12 | Iomx Therapeutics Ag | Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2, combinations and uses thereof |
| CN119176874A (zh) * | 2023-06-21 | 2024-12-24 | 康源博创生物科技(北京)有限公司 | 一种能够结合lilrb2的抗体或其抗原结合片段 |
| CN116874600B (zh) * | 2023-07-13 | 2024-07-05 | 浙江大学 | 来自纳米抗体可靶向cd163受体的短肽的制备方法及其应用 |
| CN117343346B (zh) * | 2023-12-04 | 2024-03-08 | 内蒙古大学 | 可视化识别盐酸克仑特罗的超灵敏铕基MOFs传感器及制备方法和用途 |
| WO2025232879A1 (en) * | 2024-05-10 | 2025-11-13 | Cytocares (Shanghai) Inc. | Anti-lilrb2 monospecific and bispecific antibody constructs and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002479A2 (en) | 1995-06-30 | 1997-01-23 | Yale University | Human monoclonal anti-tumor antibodies |
| US20150174203A1 (en) * | 2012-05-30 | 2015-06-25 | Icahn School Of Medicine At Mount Sinai | Compositions And Methods For Modulating Pro-Inflammatory Immune Response |
| KR20180016972A (ko) * | 2015-02-22 | 2018-02-20 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Cd137에 결합하는 항체 치료제 |
| US11680101B2 (en) * | 2017-01-27 | 2023-06-20 | Kymab Limited | Anti-OPG antibodies |
| TWI796329B (zh) * | 2017-04-07 | 2023-03-21 | 美商默沙東有限責任公司 | 抗－ilt4抗體及抗原結合片段 |
| EA202091540A1 (ru) | 2017-12-22 | 2021-03-22 | Джаунс Терапьютикс, Инк. | Антитела к lilrb2 |
| CN113056483B (zh) * | 2018-07-09 | 2025-08-01 | 戊瑞治疗有限公司 | 结合到ilt4的抗体 |
-
2021
- 2021-01-28 EP EP21750682.3A patent/EP4100439A4/en active Pending
- 2021-01-28 WO PCT/US2021/015362 patent/WO2021158413A1/en not_active Ceased
- 2021-01-28 CN CN202180026245.XA patent/CN115768793A/zh active Pending
- 2021-01-28 BR BR112022015450A patent/BR112022015450A2/pt unknown
- 2021-01-28 US US17/759,800 patent/US12596122B2/en active Active
- 2021-01-28 JP JP2022547675A patent/JP7767291B2/ja active Active
- 2021-01-28 CA CA3165532A patent/CA3165532A1/en active Pending
- 2021-01-28 AU AU2021216361A patent/AU2021216361A1/en active Pending
- 2021-01-28 KR KR1020227028453A patent/KR20220137032A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513158A5 (https=) | ||
| CN111944050B (zh) | 一种抗b7-h3抗体及其应用 | |
| CN109310764B (zh) | 高亲和力b7-h6抗体和抗体片段 | |
| JP2022500084A5 (https=) | ||
| Lin et al. | Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy | |
| CN111801353B (zh) | 针对前列腺素f2受体抑制剂的单克隆抗体和缀合物及其用途 | |
| WO2020253568A1 (zh) | 抗cd73抗体及其应用 | |
| CA3043691C (en) | Antibody binding specifically to cd66c and use thereof | |
| HK1258375A1 (zh) | 人源化抗-cll-1抗体 | |
| AU2021315882A1 (en) | Compositions including ex vivo armed T cells with multi-specific antibodies and uses thereof | |
| US20260116991A1 (en) | Monoclonal antibody for specifically recognizing glypican-3, and application thereof | |
| JP2023508277A5 (https=) | ||
| JP2020125352A (ja) | 抗−ｃｄ４３抗体およびその癌治療用途 | |
| BR112020023265A2 (pt) | uso para prevenir e tratar doenças relacionadas a células supressoras derivadas de mieloide | |
| CN118946589B (zh) | 肿瘤抗原依赖性cd40激动剂抗体 | |
| CN115916349A (zh) | 针对Lewis Y的人源化抗体 | |
| JP2022550364A (ja) | 新規抗ｐｄ－ｌ１／抗ｌａｇ－３二重特異性抗体およびその使用 | |
| WO2024227427A1 (en) | Modified antibodies, antibody fragments thereof, and antibody-drug conjugates | |
| US20250154259A1 (en) | Novel methods of therapy | |
| WO2026035616A1 (en) | Combinations for the treatment of cancer | |
| JP2025508042A (ja) | Ｌｙｐｄ３に対する抗体 | |
| WO2025064951A1 (en) | Anti-tumor antibodies | |
| CN120917143A (zh) | 抗cd25抗体及抗cd25抗体-药物偶联物 | |
| HK40004147A (en) | High affinity b7-h6 antibodies and antibody fragments |